Patents by Inventor Edward Beaumont

Edward Beaumont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11897866
    Abstract: The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: February 13, 2024
    Assignee: Padlock Therapeutics, Inc.
    Inventors: Rajesh Devraj, Gnanasambandam Kumaravel, Holly Atton, Edward Beaumont, Elise Gadouleau, Laura Gleave, Philip Stephen Kerry, Cristina Lecci, Mirco Meniconi, Nat Monck, Jordan Palfrey, Kostas Papadopoulos, Heather Tye, Philip A. Woods
  • Patent number: 11416939
    Abstract: A computer-implemented method, device, and system for communicating an impact of a financial decision or an investment strategy to a user through the use of virtual reality are provided. Providing a context for figuratively ‘seeing and feeling’ the results for a proposed financial strategy may assist the user in better understanding the impact of the financial strategy. Information provided in this context may educate the user with regards to the amount of income or savings required to achieve a goal over a time period. A goal for a user may be displayed as an image in a virtual reality scene based on gathered user information. The image representing the goal may be displayed according to a percent of clarity based on the financial amount needed to achieve the goal. The image may be changed based on the amount over a perceived virtual reality time period.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: August 16, 2022
    Assignee: Wells Fargo Bank, N.A.
    Inventors: Kav Khurana, Christopher Nicholas Mair, Claes Dahlstrand, Lakshmi Kantamneni, James E. Price, Michael Edward Beaumont, Gene C. Baker, Jr., Donald Nevills, James D. Cahill
  • Publication number: 20220084120
    Abstract: A system and computer-implemented method for use in generating retirement income from selling a non-monetary digital asset affiliated with a user are provided. Information about a user may be gathered by a processor in a computing device. A non-monetary digital asset associated with the user may be determined based on the user information. A market price for the non-monetary digital asset may be determined from a plurality of data sources. A buyer for the non-monetary digital asset may be identified. The non-monetary digital asset may then be sold to the buyer at the market value price. The proceeds from selling the non-monetary digital asset may be placed into a retirement account associated with the user. The non-monetary digital asset may be automatically sold at the market value price prior to an expiration date.
    Type: Application
    Filed: May 24, 2016
    Publication date: March 17, 2022
    Inventors: Kav Khurana, Christopher Nicholas Mair, Claes Dahlstrand, Lakshmi Kantamneni, James E. Price, Michael Edward Beaumont, Gene C. Baker, JR., Donald Nevills
  • Publication number: 20220081418
    Abstract: The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
    Type: Application
    Filed: November 9, 2021
    Publication date: March 17, 2022
    Inventors: Rajesh Devraj, Gnanasambandam Kumaravel, Holly Atton, Edward Beaumont, Elise Gadouleau, Laura Gleave, Philip Stephen Kerry, Cristina Lecci, Mirco Meniconi, Nat Monck, Jordan Palfrey, Kostas Papadopoulos, Heather Tye, Philip A. Woods
  • Patent number: 11198681
    Abstract: The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: December 14, 2021
    Assignee: Padlock Therapeutics, Inc.
    Inventors: Rajesh Devraj, Gnanasambandam Kumaravel, Holly Atton, Edward Beaumont, Elise Gadouleau, Laura Gleave, Philip Stephen Kerry, Cristina Lecci, Mirco Meniconi, Nat Monck, Jordan Palfrey, Kostas Papadopoulos, Heather Tye, Philip A. Woods
  • Publication number: 20210188810
    Abstract: The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
    Type: Application
    Filed: February 22, 2017
    Publication date: June 24, 2021
    Inventors: Rajesh Devraj, Gnanasambandam Kumaravel, Holly Atton, Edward Beaumont, Elise Gadouleau, Laura Gleave, Philip Stephen Kerry, Cristina Lecci, Mirco Meniconi, Nat Monck, Jordan Palfrey, Kostas Papadopoulos, Heather Tye
  • Patent number: 11023977
    Abstract: A computer-implemented method, device, and system for communicating an impact of a financial decision or an investment strategy to a user through the use of virtual reality are provided. Providing a context for figuratively ‘seeing and feeling’ the results for a proposed financial strategy may assist the user in better understanding the impact of the financial strategy. Information provided in this context may educate the user with regards to the amount of income or savings required to achieve a goal over a time period. A goal for a user may be displayed as an image in a virtual reality scene based on gathered user information. The image representing the goal may be displayed according to a percent of clarity based on the financial amount needed to achieve the goal. The image may be changed based on the amount over a perceived virtual reality time period.
    Type: Grant
    Filed: June 8, 2016
    Date of Patent: June 1, 2021
    Assignee: Wells Fargo Bank, N.A.
    Inventors: Kav Khurana, Christopher Nicholas Mair, Claes Dahlstrand, Lakshmi Kantamneni, James E. Price, Michael Edward Beaumont, Gene C. Baker, Jr., Donald Nevills, James D. Cahill
  • Patent number: 9963448
    Abstract: The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: May 8, 2018
    Assignee: Padlock Therapeutics, Inc.
    Inventors: Rajesh Devraj, Gnanasambandam Kumaravel, Michael F. Parker, Edward Beaumont, Lee Bowles, Steve Bromidge, Sophie Cooper, Elise Gadouleau, Laura Gleave, Philip Kerry, Adrian Kotey, Thomas Krulle, Cristina Lecci, Pui Loke, Mirco Meniconi, Nat Monck, Carl North, Jordan Palfrey, Shelley Parrott, Mark Ridgill, Heather Tye
  • Publication number: 20170166565
    Abstract: The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
    Type: Application
    Filed: December 9, 2016
    Publication date: June 15, 2017
    Inventors: Rajesh Devraj, Gnanasambandam Kumaravel, Michael F. Parker, Edward Beaumont, Lee Bowles, Steve Bromidge, Sophie Cooper, Elise Gadouleau, Laura Gleave, Philip Kerry, Adrian Kotey, Thomas Krulle, Cristina Lecci, Pui Loke, Mirco Meniconi, Nat Monck, Carl North, Jordan Palfrey, Shelley Parrott, Mark Ridgill, Heather Tye
  • Publication number: 20060231530
    Abstract: An electrical discharge machine is configured to (i) machine at least a portion of a workpiece through electrical discharge between the workpiece and a first machining electrode aligned by the electrode guide; (ii) generate a dressed machining electrode by engaging a machining electrode aligned by the electrode guide with the electrode dresser; and (iii) machine at least a portion of a workpiece through electrical discharge between the workpiece and the dressed machining electrode. Additional electrical discharge machines and methods of machining are provided.
    Type: Application
    Filed: October 18, 2005
    Publication date: October 19, 2006
    Inventors: Edward Beaumont, Donald Rowland
  • Patent number: D364798
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: December 5, 1995
    Inventors: Vernon G. Bright, Edward A. Beaumont